Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIc trial of JX11502MA tablets for acute schizophrenia in adults
CTR20241704Phase 2Active
- Sponsor
- Hengrui Therapeutics
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JX11502MA in schizophrenia, sponsored by Hengrui Therapeutics. Started May 2024; status: active.
02
Drugs
JX11502MA
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20241704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241704.